Related Experiment Video
Updated: May 31, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
[Pharmacotherapy in patients with ulcerative colitis]
Zeitschrift Fur Gastroenterologie
|July 19, 2011
Summary
This study surveyed 444 ulcerative colitis patients on medication use. Findings indicate high 5-aminosalicylic acid use but potential underuse of immunomodulatory agents, suggesting a need for further investigation into treatment patterns.
Area of Science:
- Gastroenterology
- Clinical Pharmacy
- Patient Reported Outcomes
Context:
- Ulcerative colitis (UC) management involves multiple pharmacological agents.
- Limited self-reported data exists on the prescription patterns of these UC medications.
- Understanding patient-reported medication use is crucial for optimizing UC treatment.
Purpose:
- To investigate the prescription rates of various medications in a cohort of ulcerative colitis patients.
- To explore potential associations between medication use, patient demographics, and psychosocial factors.
- To identify potential gaps or underutilization in current UC pharmacotherapy.
Summary:
- A 2005 German postal survey of 444 ulcerative colitis patients revealed 71% use 5-aminosalicylic acid, 28% use corticosteroids, and ~25% use immunomodulatory agents.
- Complementary agents were used by 36% of patients, with higher prevalence in women.
- Shorter disease duration (<11 years) was associated with increased corticosteroid use.
Impact:
- Highlights significant use of 5-aminosalicylic acid and complementary therapies in ulcerative colitis management.
- Suggests potential underuse of immunomodulatory agents, warranting further clinical evaluation.
- Identifies patient characteristics associated with specific medication prescriptions, informing personalized treatment strategies.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...